Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
3 January 2006 | Volume 144 Issue 1 | Pages 21-28
Background: Although interest in the relationship between obesity and kidney disease is increasing, few epidemiologic studies have examined whether excess weight is an independent risk factor for end-stage renal disease (ESRD).
Objective: To determine the association between increased body mass index (BMI) and risk for ESRD.
Design: Historical (nonconcurrent) cohort study.
Setting: A large integrated health care delivery system in northern California.
Participants: 320 252 adult members of Kaiser Permanente who volunteered for screening health checkups between 1964 and 1985 and who had height and weight measured.
Measurements: The authors ascertained ESRD cases by matching data with the U.S. Renal Data System registry through 2000.
Results: A total of 1471 cases of ESRD occurred during 8 347 955 person-years of follow-up. Higher BMI was a risk factor for ESRD in multivariable models that adjusted for age, sex, race, education level, smoking status, history of myocardial infarction, serum cholesterol level, urinalysis proteinuria, urinalysis hematuria, and serum creatinine level. Compared with persons who had normal weight (BMI, 18.5 to 24.9 kg/m2), the adjusted relative risk for ESRD was 1.87 (95% CI, 1.64 to 2.14) for those who were overweight (BMI, 25.0 to 29.9 kg/m2), 3.57 (CI, 3.05 to 4.18) for those with class I obesity (BMI, 30.0 to 34.9 kg/m2), 6.12 (CI, 4.97 to 7.54) for those with class II obesity (BMI, 35.0 to 39.9 kg/m2), and 7.07 (CI, 5.37 to 9.31) for those with extreme obesity (BMI
Limitations: Primary analyses were based on single measurements of exposures.
Conclusions: High BMI is a common, strong, and potentially modifiable risk factor for ESRD.
Editors' Notes
Context
Contribution
Cautions
Implications
The Editors
Author and Article Information
From the University of California, San Francisco, San Francisco, California, and Kaiser Permanente of Northern California, Oakland, California.
Disclaimer: Some data were supplied by the U.S. Renal Data System. The interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as an official policy or interpretation of the U.S. government.
Acknowledgment: The authors thank Mr. Shu-Cheng Chen of the U.S. Renal Data System for his assistance.
Grant Support: By the National Institutes of Health (grants HL71074 and DK61520).
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Chi-yuan Hsu, MD, MSc, Division of Nephrology, University of California, San Francisco, 513 Parnassus Avenue, 672 HSE, Box 0532, San Francisco, CA 94143-0532; e-mail, hsuchi{at}medicine.ucsf.edu.
Current Author Addresses: Dr. Hsu: Division of Nephrology, University of California, San Francisco, 513 Parnassus Avenue, 672 HSE, Box 0532, San Francisco, CA 94143-0532.
Dr. McCulloch: Department of Epidemiology and Biostatistics, University of California, San Francisco, 500 Parnassus Avenue, San Francisco, CA 94143.
Drs. Iribarren and Go and Ms. Darbinian: Division of Research, Kaiser Permanente, 2000 Broadway, Oakland, CA 94612.
Author Contributions: Conception and design: C.-Y. Hsu, C. Iribarren, A.S. Go.
Analysis and interpretation of the data: C.-Y. Hsu, C.E. McCulloch, J. Darbinian, A.S. Go.
Drafting of the article: C.-Y. Hsu.
Critical revision of the article for important intellectual content: C.-Y. Hsu, C.E. McCulloch, C. Iribarren, J. Darbinian, A.S. Go.
Final approval of the article: C.-Y. Hsu, C.E. McCulloch, C. Iribarren, J. Darbinian, A.S. Go.
Statistical expertise: C.-Y. Hsu, C.E. McCulloch.
Obtaining of funding: C.-Y. Hsu, C. Iribarren, A.S. Go.
Administrative, technical, or logistic support: C.-Y. Hsu, A.S. Go. ARTICLE
Body Mass Index and Risk for End-Stage Renal Disease
40 kg/m2). Higher baseline BMI remained an independent predictor for ESRD after additional adjustments for baseline blood pressure level and presence or absence of diabetes mellitus.
![]()
40 kg/m2). This relationship was not affected by blood pressure levels or diabetes.
![]()
Related articles in Annals:
This article has been cited by other articles:
![]() |
A. Shankar, C. Leng, K. S. Chia, D. Koh, E. S. Tai, S. M. Saw, S. C. Lim, and T. Y. Wong Association between body mass index and chronic kidney disease in men and women: population-based study of Malay adults in Singapore Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1910 - 1918. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lin and G. C. Curhan Kidney function decline and physical function in women Nephrol. Dial. Transplant., April 8, 2008; (2008) gfn121v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mafra, F. Guebre-Egziabher, and D. Fouque Body mass index, muscle and fat in chronic kidney disease: questions about survival Nephrol. Dial. Transplant., April 3, 2008; (2008) gfn053v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Griffin, H. Kramer, and A. K. Bidani Adverse renal consequences of obesity Am J Physiol Renal Physiol, April 1, 2008; 294(4): F685 - F696. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Jaar, R. Khatib, L. Plantinga, L. E. Boulware, and N. R. Powe Principles of Screening for Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 601 - 609. [Full Text] [PDF] |
||||
![]() |
L. F. Ramos, A. Shintani, T. A. Ikizler, and J. Himmelfarb Oxidative Stress and Inflammation Are Associated with Adiposity in Moderate to Severe CKD J. Am. Soc. Nephrol., March 1, 2008; 19(3): 593 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, B. Kissela, et al. Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 29, 2008; 117(4): e25 - e146. [Full Text] [PDF] |
||||
![]() |
S. A. Cook, H. MacLaughlin, and I. C. Macdougall A structured weight management programme can achieve improved functional ability and significant weight loss in obese patients with chronic kidney disease Nephrol. Dial. Transplant., January 1, 2008; 23(1): 263 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Schelling, H. E. Abboud, S. B. Nicholas, M. V. Pahl, J. R. Sedor, S. G. Adler, N. H. Arar, D. W. Bowden, R. C. Elston, B. I. Freedman, et al. Genome-Wide Scan for Estimated Glomerular Filtration Rate in Multi-Ethnic Diabetic Populations: The Family Investigation of Nephropathy and Diabetes (FIND) Diabetes, January 1, 2008; 57(1): 235 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Boor, K. Sebekova, T. Ostendorf, and J. Floege Treatment targets in renal fibrosis Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3391 - 3407. [Full Text] [PDF] |
||||
![]() |
M. Ferris, S. L. Hogan, H. Chin, D. A. Shoham, D. S. Gipson, K. Gibson, S. Yilmaz, R. J. Falk, and J. C. Jennette Obesity, Albuminuria, and Urinalysis Findings in US Young Adults from the Add Health Wave III Study Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1207 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. DiCecco Medical Weight Loss Treatment Options in Obese Solid-Organ Transplant Candidates Nutr Clin Pract, October 1, 2007; 22(5): 505 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Korantzopoulos, M. Elisaf, and H. J. Milionis Multifactorial intervention in metabolic syndrome targeting at prevention of chronic kidney disease ready for prime time? Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2768 - 2774. [Full Text] [PDF] |
||||
![]() |
A. M. O'Hare, A. I. Choi, D. Bertenthal, P. Bacchetti, A. X. Garg, J. S. Kaufman, L. C. Walter, K. M. Mehta, M. A. Steinman, M. Allon, et al. Age Affects Outcomes in Chronic Kidney Disease J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2758 - 2765. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ritz Metabolic Syndrome: An Emerging Threat to Renal Function Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 869 - 871. [Full Text] [PDF] |
||||
![]() |
M.-C. Beauvieux, F. Le Moigne, C. Lasseur, C. Raffaitin, C. Perlemoine, N. Barthe, P. Chauveau, C. Combe, H. Gin, and V. Rigalleau New Predictive Equations Improve Monitoring of Kidney Function in Patients With Diabetes Diabetes Care, August 1, 2007; 30(8): 1988 - 1994. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Sibley, I. H. de Boer, M. W. Steffes, J. D. Brunzell, and the Diabetes Control and Complications Trial/Epide Intra-Abdominal Fat and Elevated Urine Albumin Excretion in Men With Type 1 Diabetes Diabetes Care, July 1, 2007; 30(7): 1898 - 1900. [Full Text] [PDF] |
||||
![]() |
A. K. Bello, D. de Zeeuw, M. E. Nahas, A. H. Brantsma, S. J. L. Bakker, P. E. de Jong, and R. T. Gansevoort Impact of weight change on albuminuria in the general population Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1619 - 1627. [Abstract] [Full Text] [PDF] |
||||
![]() |
Ar. Mani, J. Radhakrishnan, H. Wang, Al. Mani, M.A. Mani, C. Nelson-Williams, K.S. Carew, S. Mane, H. Najmabadi, D. Wu, et al. Metabolic Syndrome--What We Know and What We Don't Know: LPR6 Mutation in a Family with Early Coronary Disease and Metabolic Risk Factors. Science 315: 1278-1282, 2007 J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1619 - 1623. [Full Text] [PDF] |
||||
![]() |
M Kleber, M Cybulla, K Bauchmuller, G Ihorst, B Koch, and M Engelhardt Monitoring of renal function in cancer patients: an ongoing challenge for clinical practice Ann. Onc., May 1, 2007; 18(5): 950 - 958. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Wahba and R. H. Mak Obesity and Obesity-Initiated Metabolic Syndrome: Mechanistic Links to Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 550 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. McClellan, R. Speckman, L. McClure, V. Howard, R. C. Campbell, M. Cushman, P. Audhya, G. Howard, and D. G. Warnock Prevalence and Characteristics of a Family History of End-Stage Renal Disease among Adults in the United States Population: Reasons for Geographic and Racial Differences in Stroke (REGARDS) Renal Cohort Study J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1344 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Rigalleau, C. Lasseur, C. Raffaitin, C. Perlemoine, N. Barthe, P. Chauveau, C. Combe, and H. Gin The Mayo Clinic quadratic equation improves the prediction of glomerular filtration rate in diabetic subjects Nephrol. Dial. Transplant., March 1, 2007; 22(3): 813 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. de Mutsert, M. B. Snijder, F. van der Sman-de Beer, J. C. Seidell, E. W. Boeschoten, R. T. Krediet, J. M. Dekker, J. P. Vandenbroucke, F. W. Dekker, and for the Netherlands Cooperative Study on the Adequ Association between Body Mass Index and Mortality Is Similar in the Hemodialysis Population and the General Population at High Age and Equal Duration of Follow-Up J. Am. Soc. Nephrol., March 1, 2007; 18(3): 967 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Rosamond, K. Flegal, G. Friday, K. Furie, A. Go, K. Greenlund, N. Haase, M. Ho, V. Howard, B. Kissela, et al. Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, February 6, 2007; 115(5): e69 - e171. [Full Text] [PDF] |
||||
![]() |
D. Schmidt and A. Salahudeen The Obesity-Survival Paradox in Hemodialysis Patients: Why Do Overweight Hemodialysis Patients Live Longer? Nutr Clin Pract, February 1, 2007; 22(1): 11 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Raffaitin, C. Lasseur, P. Chauveau, N. Barthe, H. Gin, C. Combe, and V. Rigalleau Nutritional status in patients with diabetes and chronic kidney disease: a prospective study Am. J. Clinical Nutrition, January 1, 2007; 85(1): 96 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. L. Bakker, R. T. Gansevoort, and D. de Zeeuw Metabolic syndrome: a fata morgana? Nephrol. Dial. Transplant., January 1, 2007; 22(1): 15 - 20. [Full Text] [PDF] |
||||
![]() |
C.-y. Hsu, A. S. Go, C. E. McCulloch, J. Darbinian, and C. Iribarren Exploring Secular Trends in the Likelihood of Receiving Treatment for End-Stage Renal Disease Clin. J. Am. Soc. Nephrol., January 1, 2007; 2(1): 81 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. H. de Boer, S. D. Sibley, B. Kestenbaum, J. N. Sampson, B. Young, P. A. Cleary, M. W. Steffes, N. S. Weiss, J. D. Brunzell, and for the Diabetes Control and Complications Trial/E Central Obesity, Incident Microalbuminuria, and Change in Creatinine Clearance in the Epidemiology of Diabetes Interventions and Complications Study J. Am. Soc. Nephrol., January 1, 2007; 18(1): 235 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cirillo, W. Sato, S. Reungjui, M. Heinig, M. Gersch, Y. Sautin, T. Nakagawa, and R. J. Johnson Uric Acid, the Metabolic Syndrome, and Renal Disease J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S165 - S168. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gomez, L. M. Ruilope, V. Barrios, J. Navarro, M. A. Prieto, O. Gonzalez, L. Guerrero, M. A. S. Zamorano, C. Filozof, and on behalf of the FATH Study Group Prevalence of Renal Insufficiency in Individuals with Hypertension and Obesity/Overweight: The FATH Study J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S194 - S200. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Reese, A. L. Caplan, A. S. Kesselheim, and R. D. Bloom Creating a Medical, Ethical, and Legal Framework for Complex Living Kidney Donors Clin. J. Am. Soc. Nephrol., November 1, 2006; 1(6): 1148 - 1153. [Full Text] [PDF] |
||||
![]() |
B. Stengel and C. Couchoud Chronic Kidney Disease Prevalence and Treated End-Stage Renal Disease Incidence: A Complex Relationship J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2094 - 2096. [Full Text] [PDF] |
||||
![]() |
E. S. Ommen, J. A. Winston, and B. Murphy Medical Risks in Living Kidney Donors: Absence of Proof Is Not Proof of Absence Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 885 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
Additional articles abstracted in ACP Journal Club Evid. Based Med., June 1, 2006; 11(3): 94 - 94. [Full Text] [PDF] |
||||
![]() |
E. Ejerblad, C. M. Fored, P. Lindblad, J. Fryzek, J. K. McLaughlin, and O. Nyren Obesity and Risk for Chronic Renal Failure J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1695 - 1702. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Chertow, C.-y. Hsu, and K. L. Johansen The Enlarging Body of Evidence: Obesity and Chronic Kidney Disease J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1501 - 1502. [Full Text] [PDF] |
||||
![]() |
M. L. Thorp Body Mass Index and Risk for End-Stage Renal Disease Ann Intern Med, May 2, 2006; 144(9): 700 - 701. [Full Text] [PDF] |
||||
![]() |
K. Kalantar-Zadeh and J. D. Kopple Body Mass Index and Risk for End-Stage Renal Disease Ann Intern Med, May 2, 2006; 144(9): 701 - 701. [Full Text] [PDF] |
||||
![]() |
Higher BMI Is a Risk Factor for Renal Failure Journal Watch (General), January 27, 2006; 2006(127): 2 - 2. [Full Text] |
||||
Read all Rapid Responses